Compare RSSS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSSS | MBOT |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 75.2M |
| IPO Year | 2008 | 2000 |
| Metric | RSSS | MBOT |
|---|---|---|
| Price | $1.85 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $3.83 | ★ $5.38 |
| AVG Volume (30 Days) | 30.5K | ★ 765.1K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | 60.27 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $28,793,922.00 | $116,887.00 |
| Revenue This Year | $1.40 | N/A |
| Revenue Next Year | $5.18 | $377.83 |
| P/E Ratio | $20.78 | ★ N/A |
| Revenue Growth | ★ 2.77 | N/A |
| 52 Week Low | $1.78 | $0.93 |
| 52 Week High | $3.38 | $2.86 |
| Indicator | RSSS | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 28.68 | 46.86 |
| Support Level | N/A | N/A |
| Resistance Level | $2.34 | $2.69 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 21.43 | 65.91 |
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from the cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.